Biofrontera Inc. (NASDAQ:BFRI) Q4 2025 Earnings Call Transcript March 19, 2026 Biofrontera Inc. beats earnings expectations.

Documents obtained by Friends of the Everglades through a court ruling is grant correspondence with FEMA about costs and reimbursement ...

Quarterly Adjusted EBITDA -- $4.9 million, a $6.3 million improvement from negative $1.4 million in the prior year, with a ...

Received FDA clearance of Investigational New Drug application (IND) for PRT12396, mutant-selective JAK2V617F inhibitor in the first quarter of 2026 Phase 1 study of PRT12396 in patients with ...

Khan knew a post-secondary education was supposed to be an investment, but one “which felt manageable considering the ratio of grants to loans at the time.” More than two-thirds of postsecondary ...

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today reported its financial results ...

Burning Rock Biotech Limited (NASDAQ: BNR, the "Company" or "Burning Rock"), a company focused on the application of next-generation sequencing (NGS) ...

NCLAT grants CSR exemption to 50 IL&FS red & amber companies due to interest expenses. Order benefits debt-ridden group.

Throughout the year, the Company reported significant positive preclinical findings for SIL204 across eight KRAS mutations and four cancer types, including first evidence of activity in gastric cancer ...

Q4 net revenue of $34.1 million, representing 31% growth quarter-over-quarter FY 2025 net revenue of $106.5 million- driven by growth in MIPLYFFA net revenue to $87.4 million 2025 EPS of $1.40 basic ...

The Nigerian Education Loan Fund said it has released more than N206bn in loans to support students in tertiary institutions across the country since the programme began.According to the fund’s daily ...

The Delhi High Court upheld the ITAT s ruling that assessment orders were invalid because the approving authority granted ...